New User? Sign Up | Sign In

Insider Trading - Keros Therapeutics Inc. (KROS)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
KROS Insider Trading Transactions for Keros Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-04-13
Purchase
2020-04-13
5:12 pm
Keros Therapeutics Inc. KROS GORDON CARL L
Director
375,200 $16 $6,003,200 1,119,812
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:13 pm
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:15 pm
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
120,000 $16 $1,920,000 2,013,102
(Indirect
Direct)
View
2020-04-13
Purchase
2020-04-13
5:16 pm
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:17 pm
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
375,200 $16 $6,003,200 1,119,812
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:18 pm
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:19 pm
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
20,000 $16 $320,000 243,856
(Direct)
View
2020-04-13
Purchase
2020-04-13
5:29 pm
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
120,000 $16 $1,920,000 2,013,102
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-04-07
Option Award
2020-04-08
9:00 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
241,222 $16 241,222
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:01 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
18,430 $16 18,430
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:02 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Regnante Keith
CFO
18,430 $16 133,622
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:02 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Regnante Keith
CFO
133,622 $16 133,622
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:03 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
696,569 $16 696,569
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
744,612 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
148,922 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
744,612 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
148,922 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
1,363,542 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
663,825 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
737,226 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
169,307 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
82,425 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
91,538 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
68,654 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
163,612 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
88,460 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
79,653 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
36,858 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
1,363,542 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
663,825 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
737,226 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
169,307 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
82,425 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
91,538 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
68,654 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
163,612 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
88,460 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
79,653 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
36,858 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
276,459 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
184,305 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
205,962 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
137,308 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
67,015 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
44,676 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
276,459 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
184,305 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
205,962 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
137,308 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
67,015 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
44,676 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
1,382,295 $0 2,013,102
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
343,270 $0 2,013,102
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
167,537 $0 2,013,102
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
1,382,295 $0 2,013,102
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
343,270 $0 2,013,102
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
167,537 $0 2,013,102
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
1,363,542 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
663,825 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
737,226 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
169,307 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
82,425 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
91,538 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
68,654 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
163,612 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
88,460 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
79,653 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
36,858 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
1,363,542 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
663,825 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
737,226 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
169,307 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
82,425 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
91,538 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
68,654 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
163,612 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
88,460 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
79,653 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
36,858 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
744,612 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
148,922 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
744,612 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
148,922 $0 1,119,812
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
1,363,542 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
663,825 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
737,226 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
169,307 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
82,425 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
91,538 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
68,654 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
163,612 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
88,460 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
79,653 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
36,858 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
1,363,542 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
663,825 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
737,226 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
169,307 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
82,425 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
91,538 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
68,654 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
163,612 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
88,460 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
79,653 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
36,858 $0 149,262
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:19 pm
N/A
N/A
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
11,169 $0 243,856
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:19 pm
N/A
N/A
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
11,169 $0 243,856
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
1,382,295 $0 2,013,102
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
343,270 $0 2,013,102
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
167,537 $0 2,013,102
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
1,382,295 $0 2,013,102
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
343,270 $0 2,013,102
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
167,537 $0 2,013,102
(Direct)
View
2020-05-29
Option Award
2020-05-29
5:19 pm
N/A
2030-05-29
Keros Therapeutics Inc. KROS Farzan Nima
Director
8,500 $28.74 8,500
(Direct)
View